Document Detail

[Comparative safety study of two commercialised vaccines against canine babesiosis induced by Babesia canis].
MedLine Citation:
PMID:  22091461     Owner:  NLM     Status:  In-Data-Review    
The safety of two vaccines available on the French market against canine babesiosis - Nobivac Piro® (NP) and Pirodog® (P) - have been evaluated. Their local, general and biochemical impacts have been compared in a controlled experimental study. Three groups were used: a control group (T) and two groups vaccinated twice at 21 days interval. All dogs presented moderate local reaction. However, either clinical and biological parameters showed that the NP group presented a significantly more intense reaction at the injection site compared to the P group. No statistical difference has been revealed between the groups P and T evolutions.
L Freyburger; L Lemaitre; C Médaille; F Oberli; L Fanchon; P Bergamo
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Parasite (Paris, France)     Volume:  18     ISSN:  1252-607X     ISO Abbreviation:  Parasite     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9437094     Medline TA:  Parasite     Country:  France    
Other Details:
Languages:  fre     Pagination:  311-8     Citation Subset:  IM    
Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.
Vernacular Title:
Etude comparative de l'innocuité de deux vaccins commerciaux contre la babésiose canine provoquée par Babesia canis.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  [Entomological survey in the historical sleeping sickness focus of Bendje (Gabon)].
Next Document:  Study of the sustained speed of kill of the combination of fipronil/amitraz/(S)-methoprene and the c...